A Florida woman has filed a new Johnson & Johnson talc powder lawsuit, alleging she suffered and developed ovarian cancer as a result of using the company’s Shower-to-Shower product and Johnson’s Baby Powder.

The plaintiff, Judy H., says that she began using the products in roughly 1970 and used them through 2015.

She files the lawsuit in New Jersey federal court alleging negligence, product liability, and breach of expressed and implied warranty, among other allegations.

Johnson & Johnson Talc Power Lawsuit Joins Others in MDL

Judy’s claim is filed as part of a large multidistrict litigation, or MDL. The MDL is centered on allegations that the company’s products, primarily Shower-to-Shower and Johnson’s Baby Powder, cause women to develop ovarian cancer. The allegations against the company primarily accuse the company of hiding the purported cancer-causing nature of its talcum based products.

The Johnson & Johnson talc powder lawsuit accuses the defendant of having known that the mineral product is cancer-causing and that there exists a correlation in tying the talc based product to ovarian cancer. The plaintiff alleged that the defendants disregarded the knowledge to increase their own sales and revenue.

The plaintiffs, like Judy H., contend that they were made to believe that the products were allegedly safe to use. Women have reportedly continued to use and apply the talcum based product to absorb moisture and odor. They have done so for decades.

However, several plaintiffs, like Judy, have suffered and developed ovarian cancer as an alleged direct and proximate result of the claimed defective nature of the talcum based powder.

Talc is an inorganic mineral and one that is used in a wide array of commercial, industrial, and cosmetic substances. And according to the Johnson & Johnson talc powder lawsuit, the products, including Johnson & Johnson’s Shower-to-Shower and Johnson’s Baby Powder are “composed almost entirely of talc.”

According to the Johnson & Johnson talc powder lawsuit, the first study conducted suggesting the association between talc and ovarian cancer was conducted in 1971. The study was conducted by Dr. W.J. Henderson and others in Cardiff, Wales, and the results were published in the Journal of Obstetrics and Gynaecology of the British Commonwealth.

Another study mentioned in the lawsuit was conducted in 1982. It was allegedly the first epidemiologic study that was performed on talc powder use in women’s genital area. According to the Johnson & Johnson talc powder lawsuit, the study was also conducted by Dr. Daniel Cramer. The Johnson & Johnson talc powder lawsuit states that the study “found a 92% increased risk in ovarian cancer with women who reported genital talc use.”

Moreover, the Johnson & Johnson talc powder lawsuit mentions that “shortly after this study was published, Dr. Bruce Semple of Johnson & Johnson visited Dr. Cramer about his study. Dr. Cramer advised Dr. Semple that Johnson & Johnson should place a warning on its talcum powder products about the ovarian cancer risks so that women could make an informed decision about their health.”

Judy’s Johnson & Johnson Talc Powder Lawsuit is Case No. 3:17-cv-04761, in the U.S. District Court for the District of New Jersey. The Johnson & Johnson Talc Powder MDL is In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation, MDL No. 16-2738, in the U.S. District Court for the District of New Jersey.